Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

13.44USD
19 Oct 2018
Change (% chg)

$-0.43 (-3.07%)
Prev Close
$13.86
Open
$14.21
Day's High
$15.09
Day's Low
$13.35
Volume
112,172
Avg. Vol
151,646
52-wk High
$31.69
52-wk Low
$12.51

Chart for

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -- -- --
ROI: -- 14.75 14.27
ROE: -- 16.24 15.99

Earnings vs. Estimates